Latest Blogs

Jun 30, 2022
Establishing a reputation of humility, collegiality, and kindness ensures that people can seek you out earlier than later, which can prevent many complications and delays in care.
Jun 10, 2022
Dr. Khalid El Bairi reports on the educational presentations and exciting directions for future research from a recent event organized by young professionals in Taroudant, Morocco.
Jun 10, 2022
At the launch of an innovative partnership to combine medical oncology, hematology, and hospice and palliative medicine into a single fellowship program, Dr. Ramy Sedhom shares perspectives on the value of combined training and the critical function of this new training pathway.
May 26, 2022
"Several valuable lessons can be learned from the Syrian conflict and the immense experience of the Syrian American Medical Society’s (SAMS) efforts, coordination, and contributions developing oncology centers in northern Syria," said Dr. M. Bassel Atassi.
Subscribe to this column

Clifford A. Hudis, MD, FACP, FASCO

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO, executive vice chair of Conquer Cancer, the ASCO Foundation, and chair of CancerLinQ. Prior to these roles, he served as chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a past president of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

Disclosure.

Jan 14, 2019
Social injustice is perpetuated when patients can't afford to participate in essential clinical research.
Oct 03, 2018
The chair-elect of the ASCO Health Equity Committee and I discuss concerns with proposed Medicaid work requirements and their impact on patients with cancer and their physicians.
Sep 11, 2018
We remain very concerned that the CMS proposal could harm Medicare beneficiaries who have cancer by triggering major cuts to physician reimbursement, especially for Part B drugs and for drugs that have been newly introduced to the market.
Aug 28, 2018
At the latest ASCO Board of Directors Meeting, we discussed countering biases, improving rural access to quality cancer care, and effectively adding more value to your ASCO membership. 
Aug 24, 2018
ASCO's "I Live to Conquer Cancer" campaign is putting a human face on the results of cancer research and the researchers who make this progress.
Aug 07, 2018
I spoke with our current ASCO president about her theme for the year, her work with the Alliance for Clinical Trials in Oncology, and her frontier spirit.

Pages